According to G1 Therapeutics 's latest financial reports the company's current EPS (TTM) is -ยฃ1.10. In 2022 the company made an earnings per share (EPS) of -ยฃ2.61 an increase over its 2021 EPS that were of -ยฃ2.74.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -ยฃ1.17 | -55.35% |
2022 | -ยฃ2.61 | -4.53% |
2021 | -ยฃ2.74 | 34.22% |
2020 | -ยฃ2.04 | -19.33% |
2019 | -ยฃ2.53 | 26.36% |
2018 | -ยฃ2.00 | -10.06% |
2017 | -ยฃ2.22 | 68.91% |
2016 | -ยฃ1.32 |